2009 grants and research awards annual report.xls

RESEARCHER
2009 Funding
Relevance of Human Leukocyte Antigen (HLA) Class 1 Genetic Diversity to Harrigan, Richard
Human and viral factors determining HIV progression and response to Harrigan, Richard
High-dimensional data analysis using probabilistic graphical models to infer the causal associations between clinical outcome and virus sequence evolution, drug resistance, and host genetic factors in the context of HIV-1 infected Harrigan, Richard
High-dimensional data analysis using probabilistic graphical models to infer the causal associations between clinical outcome and virus sequence evolution, drug resistance, and host genetic factors in the context of HIV-1 infected Harrigan, Richard
Improved screening methods for CCR5-Antagonists use by ultra deep sequencing and quantitative population-based sequencing techniques: Harrigan, Richard
Analyzes of the Phase III human clinical trials of Maraviroc (08-09).
Development and Clinical Application of a Genotypic HIV-1 Whole Genome Harrigan, Richard
Drub Resistance AssayAntiretroviral Drug Resistance and Treatment Patterns Among ARV-Treated Harrigan, Richard
Kerr, Thomas
Vancouver Multi-disciplinary collaboration of injection drug use researchers Kerr, Thomas
An investigation of injection drug use and HIV infection among drug using youth Kerr, Thomas
An investigation of injection drug use and HIV infection among drug using youth Exploring the natural history of injection drug use: a qualitative study of social Kerr, Thomas
Kerr, Thomas
The Scientific Evaluation of Supervised Injecting (SEOSI) Cohort An Investigation of the Impact of Crystal Methamphetamine Use on Sexual and Kerr, Thomas
Injection-Related Risk Behaviour among Street Youth and Injection Drug Users.
The impact of incarceration on HIV transmission and pathogenesis among injection drug users: A novel analysis using linked epidemiologic and Kerr, Thomas
Urban renewal, drug related disorder and displacement: implications for health Kerr, Thomas
and HIV risk behavior among injection drug using populations Kerr, Thomas
Evaluating the natural history of injection drug use (VIDUS II).
Exploring the natural history of injection drug use: A qualitative study of social Kerr, Thomas
and environmental influences.
A qualitative investigation of the social, structural and environmental determinants of highly active antiretroviral therapy access, discontinuation and Kerr, Thomas
Kerr, Thomas
Evaluating the natural history of injection drug use (VIDUS II).
Kerr, Thomas
Place and experiences of risk among young drug users in downtown Vancouver Development of an observational database of clinical characteristics and Montaner, Julio
outcomes among HIV + adults and children in Uganda.
TMC125-C229 - An Open-Label Trial with TMC125 in HIV-1 Infected Subjects, Who Were Randomized to a TMC125 Treatment Arm in a Sponsor-Selected Montaner, Julio
TMC125 Trial and Were Treated for at Least 48 WeeksAssessing the impacts of social, sexual and drug-use networks on HIV-positive aboriginals receiving highly active anti-retroviral therapy (HAART) in British Montaner, Julio
Evaluation and dissemination of research: expanded HIV treatment to reduce Montaner, Julio
Assessing the impact of food security and nutritional status on HIV treatment Montaner, Julio
Assessing the impact of food security and nutritional status on HIV treatment Montaner, Julio
Assessing the impact of food insecurity and malnutrition on HIV treatment Montaner, Julio
Montaner, Julio
Seek and Treat for Optimal Outcomes and Prevention in HIV & AIDS (STOP Montaner, Julio
Montaner, Julio
National Institutes of Health - National Institute of Allergy and Infectious Montaner, Julio
HIV Vaccine Design and Development Teams (Dendritic Cell Vaccine in HIV)Protocol TMC125-C214 (EAP) Version 1.1: Early Access of TMC125 in Combination With Other Antiretrovirals in Treatment Experienced HIV-1 Montaner, Julio
Infected Subjects With Limited Treatment Options Protocol 023-00 (MK-0518 Early Access): Early Access of MK-0518 in Combination With an Optimized Background Antiretroviral Therapy (OBT) in Highly Treatment Experienced HIV-1 Infected Patients With Limited to No Montaner, Julio
Salary: Longitudinal impact of adherence on HIV/AIDS disease progression: Montaner, Julio
Research Allowance: Longitudinal impact of adherence on HIV/AIDS disease Montaner, Julio
progression: implications for interventions Examining the Interplay between Adherence and Antiretroviral Treatment on Montaner, Julio
Disease Outcomes over Time in HIV/AIDS Infected Patients Urban renewal, drug related disorder and displacement: implications for health Montaner, Julio
and HIV risk behaviour among injection drug using populations Social, structural, and environmental factors mediating access and adherence Montaner, Julio
to ART among HIV positive women in low, middle, and high-income countries Social, structural, and environmental factors mediating access and adherence Montaner, Julio
to ART among HIV positive women in low, middle, and high-income countries If Hepatitis C Virus (HCV) in an Opportunistic Infection, Why has HAART not Montaner, Julio
Lead to Dramatic Improvements in Liver Disease? A Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG) Versus Raltegravir (RAL) Each Administered With a Background Regimen in HIV-I Montaner, Julio
Study Evaluating the Frequency and Factors Associated with Osteoporosis in Montaner, Julio
Effectiveness of antiretroviral therapy (ART) in preventing heterosexual Moore, David
transmission of HIV among sero-discordant couples in Eastern Uganda Mapping and contextualizing public sex work spaces and their impact on HIV Shannon, Kate
transmission dynamics: A community-based pilot research project Evaluating the role of structural inequities, gender-based violence, and power in Shannon, Kate
shaping STI/HIV transmission dynamics in public place-based sex work Wood, Evan
Evaluating the natural history of injection drug use Investigating and addressing barriers to human immunodeficiency virus (HCV) Wood, Evan
and Hepatitis C Virus (HCV) care among injection drug users Salary: An investigation of the impact of trauma and crystal methamphetamine Wood, Evan
use on injection drug use and HIV infection among drug using youth Impacts of Universal Access to HIV/AIDS Care Among HIV+ Injection Drug Wood, Evan
From research to action: Preventing HIV infection and other harms among Wood, Evan
EARLY ACS: Early Glycoprotein IIb/IIIa Inginitionin Non-ST-segment Elevation Acute Coronary Syndrome: A Randomized, Placebo-Controlled Trial Evaluating the Clinical Benefits of Early Fron-loaded Eptifibatide in the Treatment of Aymong, Eve
Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Aymong, Eve
Management of Multivessel Disease (FREEDOM Trial)Protocol SATURN: Study of Coronary Atheroma by InTravascular Ultrasound: Aymong, Eve
Effect of Rosuvastatin Versus AtorvastatiN A randomized,double-blind, active-controlled trial to evaluate intravenous and oral PRT060128, a selective and reversible P2Y12-receptor inhibitor vs. Aymong, Eve
Clopidogrel, as a novel antiplatelet therapy in patietns undergoing non-urgent Bernstein, Victoria
IICT: STICH 6400: Surgical Treatment for Ischemic Heart Failure AUDITOR STUDY - Randomized, Multicenter, Double-Blind, Placebo-Controlled, Two-Arm Parallel Group Trial of Rimonabant 20mg, for Inhibition of Atheroslerosis Progression Assessed by Carotid Artery Intima-Media Bernstein, Victoria
CL3-16257-056: Effects of Ivabradine on Cardiovascular Events in Patients with Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction. A Three-Year Randomised Double-Blind Placebo-Controlled International Bernstein, Victoria
RIMONR00961: A Pan-European Randomized, Parallel Group, Two-Arm Placebo Controlled, Double-Blind Multicenter Study of Rimonabant 20mg Once Daily in the Treatment of Abdominally Obese Patients with Impaired Fasting Bernstein, Victoria
CL3-16257-063: Effects of Ivabradine on Cardiovascular Events in Patients with Moderate to Severe Chronic Heart Failure and Left Ventribular Systolic Dysfunction - A Three Year Randomized Double-Blind Placebo-Controlled Bernstein, Victoria
NC20971: A phase III, double-blind, randomized, placebo-controlled study, to evaluate the effects of RO4607381 on cardiovascular (CV) risk in stable CHD Bernstein, Victoria
patients, with a documented recent Acute Coronary Syndrome (ACS) Buller, Christopher
In Vivo Evaluation of the WTO guide wire, a Non-GLP Study Buller, Christopher
Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL)1525004 ACROSS-Cypher: Approaches to Chronic Occlusions with Sirolimus Buller, Christopher
Stents-Cypher - Total Occlusion Study of Coronary Arteries 4EVOLUTION II: Clinical EValuation Of the Edwards Lifesciences MONARC Buller, Christopher
System for the treatment of Mitral RegUrgiTatION II 1160.67: Randomised Dabigatran Etexilate Dose Finding Study in Patients with Acute Coronary Syndromes Post Index Event with Additional Risk Factors for Cardiovascular Complications also Receiving Aspirin and Clopdogrel: Multi- Buller, Christopher
Centre, ProsPIn-vivo Acute Evaluation of Abbott Vascular Coronary Guide Wires and Buller, Christopher
Associated Interventional Devices in the Swine Arterial Vascular Model Carere, Ronald
Open Artery Trial (OAT II)RECOVER II - A Prospective Randomized Trial Investigating the use of the IMPELLA RECOVER LP 2.5 System in Patients with Acute Myocardial Carere, Ronald
Infarction Induced Hemodynamic Instability Randomized, Multinational, Multicenter, Double-blind, Placebo-controlled, Two-arm Parallel Group Trial of Rimonabant 20 mg OD For Reducing the Risk of Major Cardiovascular Events in Abdominally Obese Patients With Clustering Chan, Sammy
A phase III, double-blind, randomized placebo-controlled study, to evaluate the effects of dalcetrapib on cardiovascular (CV) risk in stable CHD patients, with a Chan, Sammy
documented recent Acute Coronary Syndrome (ACS).
CVR001-0 SNAPIST: Phase II Safety Study of Systemic Nanoparticle Paclitaxel Fung, Anthony Y-F.
Atherothrombbosis Intervention in Metabolic Syndrome with Low HDL High Fung, Anthony Y-F.
Triglycerides & Impact on Global Health Issues (AIM-HIGH) EFC 5965: Randomized, Multinational, Double-Blind Study, comparing a High Loading Dose Regimen of Clopidogrel versus Standard Dose in Patients with Unstable Angina or Non-ST Segment Elevation Myocardial Infarction Managed Fung, Anthony Y-F.
MOM-M118-006: A Randomized, Multi-Cener, Open-Label Parallel Group Feasibility Study to Determine the Safety and Efficacy of the Rationally engineering Heparin M118 vs. UFH in Subjects with Stable Coronary Artery Fung, Anthony Y-F.
Fung, Anthony Y-F.
IICT: RIVAL: Radial vs. Femoral Access for Coronary InterventionCanadian Prospective, Observational Study on the use of LMWH in the setting Fung, Anthony Y-F.
of Percutaneous Coronary InterventionProtocol EFC4912 (ACTIVE): Atrial Fibrillation Clopidogrel Trial with Irbesartan Gin, Kenneth
EFC-5826: Randomized, Multinational, Multicenter, Double-Blind, Placebo Controlled, Two-Arm Parallel Group Trial of Rimonabant 20mg OD for Reducing the Risk of Major Cardiovascular Events in Abdominally Obese Patients with Gin, Kenneth
"CGT-2168: A Randomized, Double-Blind, Parallel Group, Phase 3 Efficacy and Safety Study of CGT-2168 Compared with Clopidogrel to Reduce the Incidence of Upper Gastrointestinal Events Including Bleeding Symptomatic Ulcer Gin, Kenneth
Angina with "normal" coronary arteries: sex differences in presentation and Humphries, Karin
Sex Differences and Determinants of Health Status Post Acute Myocardial Humphries, Karin
Sex differences in Care and Health Status of Young patients presenting with Humphries, Karin
GENESIS PRAXY (GENdEr and Sex DeterminantS of Cardiovascular Disease: Humphries, Karin
From Bench to Beyond PRemature Acute Coronary SYndrome) Humphries, Karin
Primary PCI in multi-vessel coronary artery disease: the dilemma of non-culprit Humphries, Karin
Humphries, Karin
Team Grant - Health Promotion in WomenProtocol PEERLESS HF: Prospective Evaluation of Elastic Restraint to Lessen Ignaszewski, Andrew
the Effects of Heart FailureASCEND HF:Double-Blind, Placebo-Controlled, Multicenter Acute Study of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Ignaszewski, Andrew
FailureCK-LX3401- The BALANCE Study: Treatment of Hyponatremia Based on Ignaszewski, Andrew
Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation Protocol DC-452-003: ASTRONOMER - The Effect of Cholesterol Lowering on Jue, John
Progression of Aortic Stenosis in Patients with Mild to Moderate Aortic Stenosis Study Agreement for the Zyban as an Effective Smoking Cessation Aid for Jue, John
Patients following an Accute Coronary Syndrome: The ZESCA Trial Jue, John
Kerr, Charles
"RAFT" Resynchronization/Defibrillation for Advanced Heart Failure Kerr, Charles
Data Analysis: CARAF II and CAFAF II Databasics Kerr, Charles
Mancini, John
Mancini, John
Primary cARE AuDit of Global risk Management (PARADIGM) Mancini, John
Approaches to Chronic Occlusions with Sirolimu Stents-Cypher Orenstein Lyall, Teddi LyClinical Trial
'CANRACE': The Canadian Registry of Acute Coronary Events PLATO (D5130C05262) - A Randomized, Double-Blind, Parallel Group, Phase 3 Efficacy and Safety Study of AZD6140 Compared with Clopidogrel for Prevention of Vascular Events in Patients with Non-ST or ST Elevation Acute Ramanathan, Krishnan Agreement
Protocol GRACE 2: The Global Registry of Acute Coronary Events Expanded Ramanathan, Krishnan Clinical Trial
TRACER: A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of SCH 530348 in addition to standard of care in subjects with acute coronary syndrome: Thrombin Receptor Antagonist for Ramanathan, Krishnan Clinical Trial
FREEDOM: Future Revascularization Evaluation in Patients with Diabetes Ricci, Donald
Mellitus: Optimal Management of Multivessel Disease TIMI 50: PO4737-3421: A Multicenter, Randomized, double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects with a History of Atherosclerotic Disease: Saw, Jacqueline
Thrombin ReceptSATURN: Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Saw, Jacqueline
Rosuvastatin Versus Atorvastatin"SAPPHIRE" Stenting and Angioplasty with Protection in Patients at High Risk Saw, Jacqueline
for Endarterectomy (Protocol No PO6-3603)Protocol CRAD001A2401 A Facilitated Access Program to Provide Everolimus (RAD) for Maintenance Patients Completing Therapy in RAD Trials in Solid Straatman, Lynn
Canadian Institute of Health Research Chair in Device Therapy for Cardiac Tang, Anthony
ArrhythmiasASSERT - Asymptomatic AF and Stroke Evaluation in Pacemaker Patients and Tung, Stanley
Tung, Stanley
Tung, Stanley
Model 4396 Left Ventricular Lead StudyProtocol A 093, ASCEND-HF: Double-Blind, Placebo-Controlled, Multicentre Acute Study of Clinical Effectiveness of Nesiritide in Subjects with Virani, Sean
Decompensated Heart Failure'CONFIRM': Closed Loop StimulatiON: Heart Failure Indexing and Rate Virani, Sean
ModulationTHE BALANCE STUDY: Treatment of Hyponatremia based on Lixivaptan in Virani, Sean
NYHA Class III/IV Cardiac Patient Evaluation TRIDENT: 160-HF-301 - A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Effects of Intravenous BG9928 on Body Weight in Subjects with Acute Decompensated Heart Failure and Renal Virani, Sean
Edwards LifeScience Percutaneous Mitral Annulopasty Repair System: A Phase I Feasibility, Non-Randomized, Multi-Center, Prospective, Consecutive Webb, John
Registry. A Percutaneous Interventional Treatment of Mitral Regurgitation.
Webb, John
REVIVE Trial - Registry of EndoVascular Implantation of Valves in Europe Webb, John
Webb, John
Webb, John
TVI Registry: Transcatheter Valve Implantation Vancouver ExperienceProtocol 2006-06-US (PARTNER): The PARTNER Trial "Placement of AoRtic Webb, John
Webb, John
Webb, John
Cath Lab Physician/Nurse Education support.
"CINCH 2" A study of subvalvular mitral annuloplasty using the Guided Delivery Webb, John
Systems, Inc. (GDS) Accucinch Percutaneous Annuloplasty System.
Webb, John
Wong, Graham
IMPROVE-ITIICT: Global registry of Acute Coronary Events Expanded Enrollment Program, Centre for Outcomes Research, University of Massachusetts Medical School Wong, Graham
TRACER: A multi-centre, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of SCH 530348 in addition to standard of care in subjects with acute coronary syndrome: Thrombin Receptor Antagonist for Wong, Graham
ClinicETAK-442-202: A Phase 2 Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of TAK-442 in Subjects with Acute Coronary Wong, Graham
07-116 (INNOVATE-PCI): A Randomized, double-blind, active-controlled trial to evaluate intravenous and oral PRT060128, a selective and reversible P2Y12- receptor inhibitor, vs. Clopidrogel, as a novel antiplatelet therapy in patients Wood, David
Ayas, Najib
The public health impact of obstructive sleep apnea hypopnea Ayas, Najib
The role of telemedicine in the initiation of nasal CPAP Ayas, Najib
The impact of obstructive sleep apnea on injuries and crashes Efficacy and Safety of ERAXIS/ECALTA (Anidulafungin) Compared to Boyd, John
CANCIDAS (CASPOFUNGIN) in Patients with Candida Deep Tissue Infection.
Chittock, Dean
(SUGAR) Survival Using Glucose Algorithm Regulation A Randomized Trial of Glutamine and Antioxidant Supplementation in Critically Chittock, Dean
Chittock, Dean
Prophylaxis for Thromboembolism in Critical Care Trial (PROTECT Study) Chittock, Dean
Age of Blood Evalution (ABLE) StudyACCESS: A Controlled Comparison of Eritoran Tetrasodium and Placebo in Dhingra, Vinay
Patients with Severe SepsisF1K-MC-EVDP: Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Dhingra, Vinay
HSPRSN Investigative Teams development grant - Intensive Care Unit Patient Dodek, Peter
Safety TeamIICT: Active observational study of the adoption and transfer of clinical practice guidelines through education, for ventilator associated pneumonia - ABATE Dodek, Peter
IICT-Incoming: Prophylaxis of Thromboembolism in Critical Care Trial Dodek, Peter
IICT: A Randomized Trial of Glutamine and Antioxidant Supplementation in Dodek, Peter
CANHELP:Deterimining the validity of a novel questionnaire to measure Dodek, Peter
satisfaction with the end of life care in Canada Dodek, Peter
Dodek, Peter
Dodek, Peter
Dorscheid, Delbert R.
Dorscheid, Delbert R.
IL-13 and the glycomics of airway epithelial repair Dorscheid, Delbert R.
Acute lung injury: erythropoietin and the immune barrier Dorscheid, Delbert R.
Airway Inflammation and CLA to Reduce Airway Remodeling The anti-inflammatory and anti-viral properties of the dietary supplement Dorscheid, Delbert R.
Dorscheid, Delbert R.
Novel benefits for airway health by promoting epithelial anti-viral host defenses AR-06: Calfactant Therapy for Direct Acute Respiratory Distress Syndrome & Ronco, Juan
Direct Acute Lung Injury in Adults and Children A phase 3,multicentre,randomized,placebo-controlled,double-blind,three-arm study to evaluate the safety and efficacy of Tifacogin(recombinant tissue factor pathway inhibitor) administration in subjects with sever community-acquired Russell, James
Protocol RESPOND: A Phase 2 Study to Evaluate Dose and Duration of Treatment of Drotrecogin Alfa (Activated) Using Serial Measurements of Protein C in Patients With Severe Sepsis and Multiple Organ Dysfunction RESPOND: Russell, James
Association of the influence of inflammatory mediator polymorphisms with outcomes in systemic inflammatory response syndrome (SIRS) and multiple organ system failure (MOSF);and, SNP Discovery Using a Whole Genome Walley, Keith
Walley, Keith
IMPACT: Integrated and mentored pulmonary and cardiovascular training IICT: ACCORD Eye Study: Substudy of the Action to Control Cardiovascular Elliott, Thomas
Control Cardiovascular Disease in Diabetes StudyTREAT - 20010184: Trial to Reduce Cardiovascular Events with Aranesp Elliott, Thomas
CDJN608B2302: Navigator Randomized Double-Blind Placebo-Controlled Forced-Titration 2x2 Factorial Design Study of the Efficacy & Safety of Long Term Administration of Nateglinide & Valsartan in the Prevention of Diabetes & Elliott, Thomas
Prior, Jerilynn
Centre for menstrual cycle and ovulation research (CEMCOR) (CAMOS) Canadian Multicentre Osteoporosis Study - A cross sectional and Prior, Jerilynn
prospective observational study of bone density, bone strength and fracture riskAniridia, insulin resistance and anovulatory androgen excess - epidemiology, Prior, Jerilynn
Prior, Jerilynn
Knowledge translation of molimina for women Prior, Jerilynn
Perimenopausal night sweats - a four-cycle observational study a) "Is fertility affected by lifestyle?" Rhizome Cafe on January 29, 2009; b) "Is menopause a disease?" on October 28, 2008 at Little Nest; c) "Are women who self-identify as lesbians more or less susceptible to certain adverse health Prior, Jerilynn
Enzyme Replacement Therapy for Fabry Disease: A Model for the Integration of Sirrs, Sandra
Rare Disease Therapeutics into the Canadian Health Care System Thompson, David
To reduce IDDM in type 1 diabetes in the genetically at risk TRIGRA randomised parallel-group, open-label, multinational trial comparing the efficacy and safety of insulin determir (Levemir R) vs human insulin (Insulin Thompson, David
NPH) used in combination with insulin.with type 1 diabetes "OPTIMIST" - PO5587-39: Optimization of Treatment with Infliximab in a Byrne, Michael
M02-433 A multi-center, randomised, double-blind, placebo-controlled study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Maintenance of clinical remission in subjects with Crohn's disease. Clinical Study Protocol M02- Enns, Robert
A Multi-Center,Open-Label Study of the Human Anti-TNF Monoclonal Enns, Robert
Adalimumab in Subjects with Crohn's Disease (M04-690) IMPROVE -ML21035 - Individualized Management with Pegasys RBV Offering Erb, Siegfried R.
IICT/The Dimension of Consensus Recommendations on the Management of Canadian Patients with Non-Variceal Upper Gastrointestinal Bleeding: A National Cluster Randomized Trial of Multifaceted Tailored Implementation Gray, James
GS-US-174-0108: A Phase II, Double-Blind, Multi-Center, Randomized Study Comparing Tenofovir Disoproxil Fumarate, Emtricitabine Plus Tenofovir Disoproxil Fumarate, and Entecavir in the Treatment of chronic Hepatitis B Kwan, Peter
GS-US-174-0121: A Phase 3b, Randomized, Double-Blind, Double-Dummy Study Evaluating the Antiviral Efficac, Safety and Tolerability of Tenofovir Disoproxil Fumarate (DF) Monotherpy Versus Emtricitabine plus Tenofovir DF Kwan, Peter
IICT/McGill: The Dissemination of Consensus Recommendations on the Management of Canadian Patients with Non Variceal Upper Gastrointestinal Bleeding: A National Cluster Randomized Trial of a Multifaceted Tailored Lam, Eric C.S.
Vancouver Coastal Health Research Institute Established Clinician: The role of integrin linked kinase in inflammatory bowel Salh, Baljinder
Exploiting the surface molecular display property of caulobacter crescentus as Salh, Baljinder
an investigative tool for inflammatory bowel disease Tai, Isabella
Tai, Isabella
The role of SPARC in Cancer Therapy Sensitization Genomic, Imaging and Modeling Approaches to Advance Population-Based Tai, Isabella
ACHIEVE 1: A Phase 3, Randomized, Multi-centre Study to Evaluate the Efficacy and Safety of Albumin Interferon Alfa-2b (alb-IFN) in Combination with Ribavirin Compared with Peginterferon Alfa-2a (pegasys or PEG-IFNa2a) in Yoshida, Eric
VX06-950-106: A Phase 2 Study of Telaprevir (VX-950) in combination with Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) in subjects with Genotype 1 Hepatitis C who have not Achieved Sustained Viral Response with Yoshida, Eric
ACHIEVECA102: A Phase 3, Randomized, Multi-Center, Study to Evaluate the Efficacy and Safety of Albumin Interferon Alfa-2b (alb-IFN) in combination with Ribavirin compared with Peginterferon Alfa2a (PEG-INF a2a) in combination Yoshida, Eric
NV19865: A Phase II, Randomized, Double-Blind, Multicentre, Dose Finding Study Evaluating the Efficacy and Safety of the HCV Polymerase Inhibitor Prodrug (RO4588161) When Given in Combination with Pegasys and Copegus Yoshida, Eric
VX950-TiDP24-C216: A randomized, double-blind, placebo-controlled, Phase III trial of 2 regimens telaprevir (with and without delayed start) combined with pegylated interferon alfa-2a (Pegasys) and ribavirin (Copegus) in subjects Yoshida, Eric
VX-07-950-108: A Phase 3 Study of 2 Dose Regimens of Telaprevir in Combination with Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) in Yoshida, Eric
Treatment-Naive Subjects with Genotype 1 Chronic Hepatitis C Protocol P05216-112: A Phase 3, Safety and Efficacy Study of Boceprevir in Yoshida, Eric
Previously Untreated Subjects with Chronic Hepatitie C Genotype 1 NV20536: A Phase 2, Randomized, Double-Blinded, Multicenter, Dose-Finding Study Evaluating the Efficacy and Safety of the HCV Polymerase Inhibitor Prodrug (RO5024048) When Given in Combination with Pegasys and Copegus Yoshida, Eric
Dunne, James V.
Canadian Scleroderma Research Group Study DatabaseThe DETECT Study: A two-stage prospective observational cohort study in scleroderma patients to evaluate screening tests and the incidence of Dunne, James V.
pulmonary arterial hypertension and pulmonary hypertension.
A Randomized, Open-Label, Phase II/III Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation with Auto-CD34+HPC Versus Dunne, James V.
Khan, Nadia
Gender and ethnic differences in hypertension and diabetes Khan, Nadia
Sex and Ethnic Differences in Stroke Prognosis and Quality of Care Palepu, Anita
Health research of vulnerable urban populationsThe Health and Housing in Transition (HHiT) Study: A Longitudianl Study of the Health of Homeless and Vulnerably Housed Adults in Vancouver, Toronto, and Palepu, Anita
OttawaThe Health and Housing in Transition (HHiT) Study: A Longitudianl Study of the Health of Homeless and Vulnerably Housed Adults in Vancouver, Toronto, and Palepu, Anita
Protocol TIGER: A Multicenter, Randomized, Double-Blind, Comparison Study of the Safety and Efficacy of a Once-Daily Dose of Tigecycline Versus Yang, Tung
Ertapenem for the Treatment of Foot Infections in Subject With Diabetes Vancouver Coastal Health Research Institute Adler, Reva
Beliefs of Citizens in Darfur, an Exploration (BCD-E) An assessment of Canadians’ willingness-to-pay for Alzheimer’s disease Lee, Philip
medications: patients, caregivers, and the general public The use of a home-based walking program to treat orthostatic hypotension in Madden, Kenneth
McElhaney, Janet
Adjuvants and Virosomal Vaccines for the Elderly Protocol 022: A Phase III Clinical Trial to Evaluate the Efficacy, Immunogenicity, McElhaney, Janet
Safety and Tolerability of ZOSTAVAX in Subjects 50 to 59 Years of Age McElhaney, Janet
Vancouver initiative to add life to years (VITALITY)UBC Portion: Correlates of Immune Protection in Older Adults using an Ex vivo Challenge Model (Team project: Correlates of Protection Against Influenza McElhaney, Janet
Illness: From Mouse Models to Older Adults) Inflammaging, diabetes & metabolic syndrome: effect on t-cell responses to McElhaney, Janet
A Randomized, Observer Blind, Active-Controlled, Phase III Study to Demonstrate the Superior Efficacy of GSK Biologicals' Adjuvanted Influenza Candidate Vaccine (GSK2186877A), Administered Intramuscularly in Elderly McElhaney, Janet
McElhaney, Janet
Immuno-epidemiologic survey: Swine-origin influenza virus (S-OIV) McElhaney, Janet
Care of older adults with acutely compromised health (COACHNet) McElhaney, Janet
T-cell responses to influenza vaccinations in older adultsThe effect of chronic obstructive pulmonary disease on age-related changes in McElhaney, Janet
Meneilly, Graydon
Sitagliptin in the Elderly: Single Dose Study Study and manipulation of T regulatory cells in the periphery and tissues of Broady, Raewyn
patients with chronic graft us host disease Defining the role of regulatory and Th17 cells in chronic graft versus host Broady, Raewyn
diseaseCSL Behring - Canada Research Chair in Endothelial Cell Biology - Dr. Edward Conway, Edward
Conway, Edward
Characterization of Links between coagulation and immunity Conway, Edward
Molecular links between coagulation and innate immunity Conway, Edward
Familial Myelodysplasia and Acute Myeloid Leukemia Conway, Edward
NIH-Transplantation of G-CSF stimulated marrow vs blood Forrest, Donna
A Study Investigating the Stem Cell Properties of Philadelphia Positive Chronic Forrest, Donna
Myeloid Leukemia Patients Receiving Therapy with Imatinib. CA180035 - A Randomized Two-Arm, Multi-center, Open-Label Phase II Study of BMS354825 Administered Orally at a Dose of 70 mg Twice Daily or 140 mg Once Daily in Subjects with Chronic Myeloid Leukemia in Accelerated Phase or Forrest, Donna
CAMN107A2109: An Open-Label, Multicentre, Expanded Access Study of Oral AMN107 in Adult Patients with Imatinib (Glivic/Gleevec - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis Accelerated Phase or Forrest, Donna
CLBH589B2202: A Phase II, Multicentre Study of Oral LBH589 in Patients with Chronic Phase Chronic Myeloid Leukemia with Resistant Disease Following Forrest, Donna
treatment with at Least Two BCR-ABL Tyrosine Kinase Inhibitors CLBH589B2211: A Phase II, Multicentre Study of Oral LBH589 in Patients with Accelerated Phase or Blast Phase (Blast Crisis) Chronic Myeloid Leukemia with Resistant Disease Following Treatment with at Least Two BCR-ABL Tyrosine Forrest, Donna
CAMN107A2303: A Phase III Multi-Centre, Open-Label, Randomized Study of Imatinib versus Nilotinib in Adult Patients with Newly Diagnosed Philadelphia Chromosome Positive (PH+) chronic Myelogenous Leukemia in Chronic Phase Forrest, Donna
3160A4-3000WW: A Phase 3 Randomized, Open Label Study of Bosutinib Versus Imatinib in Subjects with Newly Diagnosed Chronic Phase Philadelphia Forrest, Donna
Chromosome Positive Chronic Myelogenous Leukemia Hogge, Donna E.
Hogge, Donna E.
Enzyme variants as biomarkers of prostate cancer and anthracycline-based Hogge, Donna E.
Development of diphtheria toxin fusion proteins as therapy for acute myeloid Hogge, Donna E.
Hogge, Donna E.
Stem Cell Network (SCN) - Networks of Centres of Hogge, Donna E.
Canadian Cord Blood Stem Cell Initiative CLI-037: A Phase III Randomized Study of Cloretazine (VNP40101M) and Cytosine Arabinoside (AraC) in Patients with Acute Myeloid Leukemia in First Hogge, Donna E.
RelapseCR-ECP-001 Safety, Biological and Clinical Efficacy of Two Intensity Levels of Theralux Extracorporeal Photochemotherapy in Subjects with Extensive Hogge, Donna E.
Chronic GVHD Refractory or Intolerant to Standard Therapy M05-756: A Phase I Study of ABT-869 in Patients with Refractory or Relapsed Hogge, Donna E.
Acute Myelogenous Leukemia (AML)or Myelodysplastic Syndrome (MDS) Analysis of stem cells using a new high-throughput technology for interrogating Humphries, Keith
Humphries, Keith
Engineered advances for clinical applications of gene therapy Stem Cell Network (SCN) - Networks of Centres of Generation of normal, expanded and leukemic HSCs from novel cell sources Humphries, Keith
Stem Cell Network (SCN) - Networks of Centres of Humphries, Keith
Stem Cell Network (SCN) - Networks of Centres of Humphries, Keith
Lansdorp, Peter
Replicative shortening of telomeres in human cells Lansdorp, Peter
Stem cells for the treatment of bone marrow failure The role of telomere organization, structure, and function in the pathology of Lansdorp, Peter
Lansdorp, Peter
Chromatin marks in normal and malignant stem cells A phase III randomized, open-label, multi-center study of nilotinib versus imatinib in adult patients with Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia in chronic phase (CML-CP) who have suboptimal Leger, Chantal S.
Protocol CAMN107ACA01: A Canadian Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (Glivec(R))/Gleevec(R)) - Resistant or - Intolerant Chronic Myeloid Leukemia in Leitch, Heather
A Randomized, Double-Blind, Placebo-Controlled, Multicente Study Evaluating Epoetin Alfa Initiated at 40,000 IU Every Week or 80,000 IU Every Week Versus Placebo in Subjects With IPSS Low- or Intermediate-1 Risk Leitch, Heather
Leitch, Heather
Donation to Hematology Group at SPH in support of research activities.
Leitch, Heather
Molecular Diagnosis of Myelodysplastic Syndromes A1501073: Prospective, Open-Label, comparative, Multicenter Study of Voriconazole Compared to Itraconazole for the Primary Prophylaxis of Invasive Fungal Infections (IFI) in Subjects with Allogeneic Hematopoietic Stem Cell Narayanan, Sujaatha
Maribavir 1263-300: A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus Disease in Recipients of Allogeneic Stem Cell Narayanan, Sujaatha
Nevill, Thomas
IICT Incoming: A Phase III Study of the addition of Gemtuzumab Ozogamicin (Mylotarg) during induction therapy versus standard induction with Daunomycin and Cytosine Arabinoside followed by consoldiation and subsequent Nevill, Thomas
103 PH GL 2007 CL003: A Phase 2, Randomized, Open-Label Study of Single Agent Azacitine (Vidaza) vs. Single Agen MGCD0103 vs. Azacitine in Combination with MGCD0103 for the Treatment of Elderly Subjects with Newly Nevill, Thomas
20060198: A Randomized, Double-Blind, Placebo Controlled Study Evaluating the Efficacy and Safety of Romiplostim Treatment of Thrombocytopenia in Nevill, Thomas
Subjects with Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)P05090: Phase II Study of Posaconazole for the Early Treatment of Refractry Power, Maryse
Cristiano Oncology Research and Trust Fund: SPH Division of Hematology Ramadan, Khaled
Schrader, John W.
Canada Research Chair Tier I in immunology - John Schrader Shepherd, John
A phase III study of ST1571-106 versus Interferon-a (IFN-A) combined with Cytarabine (Ara-C0 in patients with newly diagnosed previously untreated Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia in Shepherd, John
Smith, Clayton
G-CSF mobilized PBSCT vs BM Transplant, A CBMTG consortium studyDevelopment of bioinformatic tools for flow cytometric high throughput Smith, Clayton
Stem Cell Network (SCN) - Networks of Centres of Smith, Clayton
Smith, Clayton
Canada Research Chair in cell therapies for Dr Clayton SmithRandomized Phase III Study of Thalidomide and Prednisone as Maintenance Therapy Following Autologous Stem Cell Transplant in Patients with Multiple Song, Kevin
MyelomaMM016: A Multicentre, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated subjects With Multiple Song, Kevin
MyelomaDefibrotide For the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopietic Stem Cell Transplant Patients: A Historically-Controlled, Multi- Song, Kevin
Centre Phase 3 Study to Determine Safety & Efficacy CLBH589B2203: A Phase II Study of LBH589 in Adult Patients with Multiple Myeloma Who have Received at Least Two Prior Lines of Therapy and Whose Song, Kevin
Disease is Refractory to the Most Recent Line of Therapy CC-5013-MM-020/IFM 07-01: A Phase III, Randomized, Open-Lable, 3-Arm Study to Determine the Efficacy and Safety of Lnealidomide (Revlimid) plus LowDose Dexamethasone when given until Progressive Disase for 18 4-week Song, Kevin
PX-171-003: An Open-Label, Single Arm, Phase II Study of Carfilzomib in Song, Kevin
Patients with Relapsed and Refractory Multiple MyelomaDOXIL-MMY-3001: Randomized Controlled Study of DOXIL/CAELYX (doxorubicin HCL liposome injection) and Velcade (bortezomib) or Velcade Sutherland, Heather
Monotherapy for the Treatment of Relapsed Multiple Myeloma Protocol: C0328T06 -A Phase 2, Randomized, Double-blind, Placebo-controlled Study Comparing the Combination of CNTO328 (Anti-IL-6 Monoclonal Antibody) and Velcade versus Velcade Alone in Subjects with Relapsed or Sutherland, Heather
Refractory Multiple Myeloma268866138-MMY-2052: Safety and Efficacy of VELCADE in Relapsed and/or Refractory Multiple Myeloma Patients with Impaired Renal Function (A Phase Sutherland, Heather
2b Trial)Data Capture Development Project for Chronic Lymphocytic Leukemia: Pilot Study based at the Hematology Clinical Trials Unit - for consideration of future Toze, Cynthia
(EXJADE - CICL670AUS03) An Open-Label, Safety and Tolerability Study of Deferasirox for Treatment of Transfusional Iron Overload in Low-Risk and INT- Vickars, Linda M.
1, Myelodysplastic Patients Using Serum Ferritin Monitoring Protocol McMaster R-ITP: A Randomized, Double Blind, Placebo Controlled Pilot Trial of Rituximab for Non-Splenectomized Adults with Acute Immune Vickars, Linda M.
Thrombocytopenic Purpura Receiving Standard Treatment (R-ITP) Vickars, Linda M.
Vickars, Linda M.
A Safety and efficacy trial evaluating the use of apixaban in the treatment of Vickars, Linda M.
symptomatic deep vein thrombosis and pulmonary embolismA safety and efficacy trial evaluating the use of Apixaban for the extended Vickars, Linda M.
treatment of deep vein thrombosis and pulmonary embolism.
A multinational, multicenter, randomized, double-blind study comparing the efficacay and safety of AVE5026 with enoxaparin for the primary prevention of Vickars, Linda M.
venous thromboembolism in acutely ill medical patients with restricted mobility.
Vickars, Linda M.
DonationsIICT: Review of Patients at St. Paul's Hospital With Immune Phenomena Treated With Rituximab; Clinical and Laboratory Characteristics and Outcome - Vickars, Linda M.
Av-Gay, Yossef
Role of cholesterol in tuberculosis infection Molecular analysis of Mycobacterium tuberculosis protein kinases and Av-Gay, Yossef
Protein Tyrosine Phosphatase A (PtpA) Dependent Mycobacterial Manipulation Av-Gay, Yossef
Av-Gay, Yossef
Development of nitric oxide delivery devise for treatment of pandemic flu Av-Gay, Yossef
Mycobacterial cholesterol metabolism: a key piece in the pathogenesis puzzle? Av-Gay, Yossef
13,495 Nitric Oxide Coated Medical Devices
Characterization of interaction between Mycobacterium tuberculosis PtpA and Av-Gay, Yossef
Av-Gay, Yossef
Protein phosphatase A signaling in mycobacterium tuberculosis pathogenesis Molecular analysis of Mycobacterium tuberculosis protein kinases and Av-Gay, Yossef
Av-Gay, Yossef
SC: Examination of Dentanox's Vaporized Anti-infective Gas Delivery System Brunham, Robert
290,941 Development of chlamydia T Cell
Brunham, Robert
Brunham, Robert
Predictors of Antiretroviral Pharmacokinetics in HIV-Infected Women with Burdge, David
Virologic Suppression on Combination Antiretroviral Therapy Burdge, David
Mechanisms of aging following exposure to HIV antiretriviral drugs Cherkasov, Artem
Functional Genomics for Emerging Infectious Diseases Biomarkers of oxidative strees: an evaluation of nutrient-gene interactions in Chow, Anthony
Life at the margins: An interdisciplinary analysis of the social determinants of Chow, Anthony
Chow, Anthony
The role of ABCA1 in the central nervous system Grigg, Michael E.
Role of the Mycobacterial Lipoamide Dehydrogenase in the Pathogenesis of Hmama, Zakaria
Translational TB Research: Identification of Novel Drug targets and Hmama, Zakaria
Enhancing the efficacy of conventional BCG: Optimal stimulation of dendritic Hmama, Zakaria
Rational design of an effective TB Vaccine: Immunology-driven reshaping of Hmama, Zakaria
Hmama, Zakaria
40,000 Testing a novel TB vaccine
Patrick, David
1,000,000 Broaden implementation/evaulation-bugs need drugs
Posaconazole P05090: A Phase II Study of Posaconazole for the Early Phillips, Peter
Treatment of Refractory Fungal Infections Phillips, Peter
A Retrospective Review of Crytococcus Gattii Infection in British Columbia Phillips, Peter
IICT: A retrospective review of crytococcus gatti infection in British Columbia Phillips, Peter
If Hepatitis C Virus (HCV) in an Opportunistic Infection, Why has HAART not Pick, Neora
Lead to Dramatic Improvements in Liver Disease? If Hepatitis C Virus (HCV) in an Opportunistic Infection, Why has HAART not Pick, Neora
Lead to Dramatic Improvements in Liver Disease? Reiner, Neil E.
Functional Genomics for Emerging Infectious Diseases Reiner, Neil E.
Reiner, Neil E.
Identification of Mycobacterium tuberculosis virulence factors by pathogen Reiner, Neil E.
effector protein screening in yeast (PEPSY) Identification of mycobacterium tuberculosis virulence factors by pathogen Reiner, Neil E.
effector protein screening in yeast (PEPSY) Reiner, Neil E.
INDEL therapeutics for the treatment of infectious diseaseIdentification of host proteins targeted by mycobacterium tuberculosis effectors Reiner, Neil E.
linked to disruption of vacuolar protein sorting Mapping the scope, location, an delivery of public health nursing services for Rekart, Michael L.
Rekart, Michael L.
500,000 Narrowing the gap between men who have sex
Steiner, Theodore
Mechanisms of Innate Immune Signalling by Enteroaggregative E. coli Flagellin Steiner, Theodore
Mechanisms of Toll-like receptor 5 signalling in response to bacterial flagellin Immunomodulation of Regulatory Mechanisms in Mucosal Immunity: A Multi- Steiner, Theodore
Disciplinary Bench-to-Bedside Approach to the Study and Treatment of IBD Steiner, Theodore
48,500 Role of bacterial flagellin in inflammatory bowel disease
Sentinal Surveillance for Influenza Requiring Hospital Admission in Canadian Stiver, Grant
Adults and Vaccine Safety Surveillance in Health Care Workers Protocol V520-023 A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase II Proof-of-Concept Study to Evaluate the Safety and Efficacy of a 3-Dose Regimen of the Merck Adenovirus Serotype 5 HIV-1 gag/pol/nef Tyndall, Mark
To each her own: sex work typologies, intimate relationships, and their impact Tyndall, Mark
on HIV risk for female sex workers in Vancouver DTES An examination of injection drug use sites: the influence of social and physical Tyndall, Mark
context upon drug-related harms and public health interventions An interventional HIV research program to reduce transmission and enhance Tyndall, Mark
antiretroviral treatment outcomes among highly marginalized populations Exploring the social structural dynamics of health barriers and determinants of Tyndall, Mark
women in Vancouver's survival sex trade: an ethnographic study The Knowledge Cycle at Providence Health Care: From Curiosity to Lefebvre, Yvonne
Lefebvre, Yvonne
Donation for BioPartnering Conference.
Lefebvre, Yvonne
Project #7 - A Phase I/II Trial to Assess the Clinical and Biologic Effects of Targeting in Hsp27 with a Second Generation Antisense Oligonucleotide in Chi, Kim Nguyen
NO16966C: 2x2 Factorial Randomized Phase III Study of Intermittent Oral Capecitabine in Combination With Intravenous Oxaliplatin (Q3W) ("Xelox") With/Without Intravenous Bevacizumab (Q3W) vs Bolus & Continuous Infusion Klimo, Paul
Fluorouracil Intra.
CA042: An Open-Label Phase II Study of weekly ABI-007 As First line Therapy Klimo, Paul
for Patients with Metastatic Breast Cancer NO147 (FACT-FOLFOX and Cetuximab Trial) A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) with or without Cetuximab (C225) after Curative Resection for Patients with Stage III Colon Klimo, Paul
The BETH Trial: A multi-center phase III randomized trial of adjuvant therapy for patients with HER2-positive node-positive or high risk node-negative breast cancer comparing chemotherapy plus trastuzumab with chemotherapy plus Klimo, Paul
Protocol EPPIC (KRM 307): A Phase III, Randomized, Double-Blind, Placeco-Controlled Study of AST-120 for Prevention of Chronic Kidney Disease Progression in Patients With Moderate to Severe Chronic Kidney Disease Chiu, Anthony
Protocol EPPIC (KRM 307): A Phase III, Randomized, Double-Blind, Placeco-Controlled Study of AST-120 for Prevention of Chronic Kidney Disease Progression in Patients With Moderate to Severe Chronic Kidney Disease Chiu, Anthony
Randomized, open-label 2-arm parallel design comparator study of the effect of Adalat XL compared to dilitiazem (Tiazac XC) on proteinuria and blood pressure in patients with diabetes and mild to moderate hypertension, when used as an Chiu, Anthony
Copland, Michael
Frequent hemodialysis clinical trial: Nocturnal Clinical Center Duncan, John A.
SHARP: Study of Heart and Renal Protection Randomized, Open-label 2-arm Parallel Design Comparator Study of the Effect of Adalat XL Compared to Diltiazem (Tiazac XC) on Proteinuria and Blood Pressure in Patients with Diabetes and Mild to Moderate Hypertension, When Duncan, John A.
An economic and epidemiologic analysis of donation after cardiac death Gill, Jagbir
24-Week Feasibility Study to Evaluate Replacement of Calcineurin Inhibitor (CNI) With Simulect In CNI Intolerant Long-Term Kidney Transplant Recipients Gill, John
Treated With Mycophenolic Acid and Steroids (REPLACE study) Gill, John
Access to kidney transplantation in B.C. and Alberta Gill, John
Access to kidney transplantation in BC and Alberta ACE-Inhibition for the Preservation of Renal Function and Patient Survival in Gill, John
Kidney TransplantationThe use of Thymoglobulin in a Calcineurin Inhibitor and Steriod Minimiation Gill, John
ProtocolObservational study of late post renal transplant anemia and secondary Gill, John
Jastrzebski, Jacek
Evaluation of IGRAs for TB screening in dialysis patients A study to evaluate the use of rosuvastatin in subjects on regular hemodialysis: An assessment of survival and cardiovascular events (AURORA)(4522IL-0096) A double-blind, randomised,multicentre,phaseIIIb,parallel-group study to Jung, Beverly
Short Title: CERA for Hemodialysis Population (version 1.1) A Randomized, Controlled, Open-Label, Multi-Center, Parallel-Group Study to Compare the Efficacy and Safety of RO0503821 With That of Darbepoetin Alfa Administered Kiaii, Mercedeh
IntravenouslyA Randomized Control Trial Comparing Combined Cardiology, Kidney and Diabetic Care Clinic CCKDC to Current Therapy Received In Multiple Clinics: Levin, Adeera
Levin, Adeera
Study of Heart and Renal Protection (SHARP) Levin, Adeera
IICT:REPEAT Study: Resistance to Erythropoetin Effectiveness Algorithm Trial IICT: CANPREDDICT: Canadian Study of Prediction of Risk and Evolution to Levin, Adeera
1,341,597
Dialysis, Death and Interim Cardiovascular Events Over TimeIICT: Pryrophospahate levels and vascular calcificaiton in peritoneal dialysis Levin, Adeera
Cellular mechanisms of vascular dysfuntion in human patients with chronic Levin, Adeera
Barton, Jason
Neuropsychology of vision and eye movementsCanada Research Chair for Dr. Jason Barton in Neuropsychology of vision and Barton, Jason
Processing of face recognition in patients with occipitotemporal lesions after Barton, Jason
The context and effects of trial history on saccades and their status in Barton, Jason
Benavente, Oscar
Secondary Prevention of Small Subcortical Strokes (SPS3) UBC - Coordinating Center: Secondary Prevention of Small Subcortical Strokes Benavente, Oscar
Benavente, Oscar
1,457,221
SPS3 Master account: Secondary Preventation of Small Subcortical Strokes Briemberg, Hannah
IICT: A Pilot Study of Etanercept in Dermatomyositis ALS-TAL-201: A Multinational, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Parallel-Group Study to Assess the Efficacy, Tolerability and Safety Briemberg, Hannah
of Talampanel in Subjects with Amyotrophic Lateral Sclerosis (ALS) PrioNet - Networks of Centres of Excellence Cashman, Neil
Prion Protein Conversion in Disease: the "Demiglobule" HypothesisCanada Research Chair in Neurodegeneration and Protein Misfolding Diseases Cashman, Neil
Cashman, Neil
PrioNet - Networks of Centres of Excellence Cashman, Neil
Pathogenesis & Bioassay PlatformMisfolding-Specific Epitopes of Superoxide Dismutase 1 as Immunotherapy Cashman, Neil
Novel TrkC small molecule agonists and their use in Amyotrophic Lateral Cashman, Neil
PrioNet - Networks of Centres of Excellence Cashman, Neil
PrioNet - Networks of Centres of Excellence Cashman, Neil
Cashman, Neil
CRA: Protein Misfolding Algorithm Technology Devonshire, Virginia
MS COSTAR Data Entry for the Genetic Suseptibility to MS Study CFTY720D2201E1/Ext.to CFTY720D2201: Extension of the Dble-Blind Randomized Placebo-Controlled Parallel-Group Multicentre Study Evaluating Safety Tolerability&Effect on MRI Lesion Parameters of FTY720 vs Placebo in Devonshire, Virginia
CFTY720D2301: A 24-Month, Double-Blind, Randomized, Multicenter, Placebo-Controlled, Parallel-Group Study comparing Efficacy and Safety of FTY720 1.25mg and 0.5 mg Administered Orally Once Daily Vs Placebo in Patients with Devonshire, Virginia
101-MS-322: An Open-Label, Multicenter Extension Study to Evaluate the Safety and Tolerability of Natalizumab Following re-Initiation of Dosing in Multiple Sclerosis Subjects who have Completed Studies C1801, C-1802, or C- Devonshire, Virginia
CFTY: 720D2302 - A 12 month double-Blind, Randomized, Multicenter, Active-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 0.5mg and 1.25 mg fingolimod (FTY720) Administered Orally Once Daily Versus Devonshire, Virginia
A Double-Blind, Randomized, Multicenter, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 1.25mg FTY720 Administered Devonshire, Virginia
Orally Once Daily vs. Placebo in Patients with Primary Progressive Multiple.
CFTY720D2302E1: 12-Month, Double-Blind, Randomized, Multicenter, Active-Controlled Parallel-Group study Comparing the Efficacy and safety of 0.5 mg and 1.25mg Fingolimod (FTY720) Adminsitered Orally Once Daily Versus Devonshire, Virginia
International, multi-centre, single-arm, open-labe, 12-week phase IIIb study to evaluate RebiSmart suitability for self-injection of Rebif New Formulation (RNF) Devonshire, Virginia
in multidose cartridges in patients with relapsing form.
An extension of the 24-month, Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of FTY720 1.25mg and 0.5mg Administered Orally Once Daily Versus Placebo in Patients Devonshire, Virginia
In vivo PET and behaviorial study of the effect of striatal implantation of Retinal Doudet, Doris
Pigment Epithelial cells in a primate model of Parkinson' disease Doudet, Doris
CIHR Team in Parkinson's disease-Core D-Animal Core Alternate Mechanisms of Action of Striatal Retinal Pigment Epithelial Cells Doudet, Doris
Implants in a Rodent Model of Parkinson's Disease Feldman, Howard
Create the Canadian Dementia Knowledge Translation Network (CDKTN) Feldman, Howard
Frontotemporal Lobar Degeneration with Ubiquitinated Inclusions: Genetic, Feldman, Howard
Clinical, Pathological and Biomarker StudiesELND005-AD201: A Randomized, Double-Blind, Placebo-Controlled, dose-Ranging, Safety and Efficacy Study of Oral ELND005 (AZD-103) in Alzheimer's Hsiung, G.Y.Robin
A9951002: A Phase 2 Multicentre, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, and Pharmacokinetics of Multiple Hsiung, G.Y.Robin
Doses of PF-04360365 in Patients with Mild to Moderate Alzheimer's Disease A Dose Ranging, Randomized, Double Blind, Parallel-Group Placebo- Controlled Multi-Center Study of RO5313534 Used as Add-On to Donepezil Hsiung, G.Y.Robin
Treatments in Patients with Mild to Moderate Symptoms of Alzheimer's DiseaseHealthcare Resource Utilization for Patients with Alzheimer's Dementia by Hsiung, G.Y.Robin
Genetic epidemiology of dementias: genomewide association study and gene- Hsiung, G.Y.Robin
Analysis of blood protein biomarkers using microarray RNA expression profiling Hsiung, G.Y.Robin
Hsiung, G.Y.Robin
Research in Alzheimer Disease and related neurodegenerative disorders Hsiung, G.Y.Robin
Research in Alzheimer Disease and related neurodegenerative disorders Illes, Judy
National core for integrated neuroethics in Canada(NCINC) Illes, Judy
Canada Research Chair in neuroethics for Dr. Judy Illes Start-up Funds: Development and implementation of a clinical neuroethics Illes, Judy
Illes, Judy
Advanced neuroimaging ethical, legal and social issues Stem Cell Network (SCN) - Networks of Centres of Illes, Judy
Stem cells to treat spinal cord injury (CT8) British Columbia Rural and Remote Health Research Network - Michael Smith Foundation for Health Alzheimer disease in remote First Nations communities: Nurturing knowledge, Illes, Judy
British Columbia Network for Aging Research - Michael Smith Foundation for Health Research Jacova, Claudia
Functional MRI of music processing in dementia: a pilot study The Alzheimer Drug Therapy Initiative Clinical Meaningfulness in Alzheimer Jacova, Claudia
Development of a computer-based screening test to support evaluation of Jacova, Claudia
cognitive impairment and dementia in British Columbia NO1276: An international, double-blind, randomized, multi-center, parallel group, historical-control conversion to monotherapy study to evaluate the efficacy and safety of brivaracetam in subjects (<16 to 75 years old) with partial Javidan, Mano
NO1315: An open-label, multinational, multicenter, followup study to evaluate the long-term safety and efficacy of brivaracetam, used at a flexible dose up to a maximum of 150 mg/day in subjects ages 16 years or older suffering from Javidan, Mano
RESPECT - Randomized Evaluation of Recurrent Stroke comparing PFO Johnston, Dean C.
Closure to Established Current Standard of Care Treatment (IDE #G990318) U2786g: Phase II/III Randomized Double-Blind Parallel-Group Placebo-Controlled Study to Evaluate the Safety and Efficacy of Rituximab in Adults with Kastrukoff, Lorne
Primary-Progressive Multiple Sclerosis (PPMS) Phase II, multicenter, randomized, parallel-group, partially blinded, placebo and Avonex controlled dose finding study to evaluate the efficacy as measure brain Kastrukoff, Lorne
MRI lesions, and safety of 2 dose regimens of ocrelizumab in patiens Kastrukoff, Lorne
Li, David
Dynamic suppression of pathological brain oscillations in Parkinson's disease McKeown, Martin
McKeown, Martin
Team for monitoring and control of abnormal brain dynamics The MaMs Study, Malignancy and Multiple Sclerosis: incidence and impact of Medicine, Head
Oger, Joel
Neuro-Immunology ResearchProtocol LTS6048: Extension of Protocol LTS6048, A Phase II Study of the Safety & Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis with Oger, Joel
Randomized Double-Blind Placebo-Controlled Parallel Group Design Study to Evaluate the Efficacy and Safety of Teriflunomide (HMR1726D) in Reducing the Oger, Joel
Frequency of Relapses and Delaying the Accumulation of Physical Disabil.
MBP8298-01: Double-Blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of MBP8298 in Subjects with Secondary Progressive Oger, Joel
Multiple SclerosisMS-F203 Extension Study: Open-Label Extension Study to Evaluate the Safety,Tolerability and Activity of Oral Fampridine-SR in Subjects with MS who Oger, Joel
Oger, Joel
Thymectomy in Non-Thymomatour MG Patients on Prednisone MBP8298-SP-02: An Open-Label Follow-on Study to Assess the Ongoing Oger, Joel
Safety of MBP8298 in Subjects with Secondary Progressive Multiple Sclerosis Long-Term Extension of the Multinational, Double-Blind, Placebo controlled Study EFC6049 (HMR 1726D/3001) to Document the Safety of Two Doses of Oger, Joel
Teriflunomide (7 & 14mg) in Patients with Multiple Sclerosis with Relapses Oger, Joel
A phase II, double-blind, randomized, multi-center, adaptive dose-ranging, placebo-controlled, parallel-group study evaluating safety, tolerability and efficacy on MRI lesion parameters and determining the dose response curve of Oger, Joel
Quandt, Jacqueline
A novel role of SPARC in multiple sclerosis regenerative therapies Rieckmann, Peter
New faculty start-up funds - MS Research Program Protocol: A4M105038 - Randomized, Double-Blind, Placebo-Controlled, ParallelGroup, Dose-Ranging Study to Investigate the MRI Efficacy and the Safety of 6 Months Administration of Firategrast (150-1200mg twice daily) in Subjects with Rieckmann, Peter
Molecular and functional aspects of recovery from acute relapses in patients Rieckmann, Peter
Effects of Aerobic Exercise on Side Effects of Disease Modifying Therapy with Rieckmann, Peter
s.c. Interferon Beta-1b in Patients with Multiple Sclerosis Rieckmann, Peter
Ruth, Thomas
Ruth, Thomas
CIHR Team in Parkinson's disease-Core C-Imaging Core Ruth, Thomas
Development of Radiotracers Based on Oligonucleotide Labelling Sadovnick, A. Dessa
Western Pacific Research and Training Centre Sadovnick, A. Dessa
Western Pacific Research and Training Centre Investigation of treatment related compulsive behaviours and impulse control Sossi, Vesna
Stoessl, A Jonathan
Canada Research Chair Tier I in Parkinson's Disease for Dr. Jon Stoessl Stoessl, A Jonathan
The natural history of sporadic and inherited Parkinson's disease Stoessl, A Jonathan
Expectation, the placebo effect and dopamine release in Parkinson's disease Stoessl, A Jonathan
Protocol 6002-US-025 - A Open-Label, Multicentre, Study of the Continued Safety of Istradefylline in Subjects with Parkinson's Disease Who have Recently Stoessl, A Jonathan
Completed One Year of Treatment with Istradefylline MSFHR research unit in Parkinson's disease and monoaminergic function in Stoessl, A Jonathan
Stoessl, A Jonathan
CIHR team in Parkinson's disease-Core A-Clinical & Administrative Core CIHR Team in Parkinson's disease-Core B-Biostatistics & Mathematical Stoessl, A Jonathan
PET Scanning in Assoc with a Multi-Center, Randomized, Double-Blind, Sham surgery controlled Study of CERE-120 (Adeno Associated Virus Serotype 2 {AAV2}-Neurturin {NTN} to Assess the Efficacy and Safety of Bilateral Stoessl, A Jonathan
Stoessl, A Jonathan
The effect of reward expectation and dopamine release on the mechanism of Stoessl, A Jonathan
the placebo effect in Parkinson's disease Stoessl, A Jonathan
Complications of Parkinson's disease: The dopaminergic basis of depression Stoessl, A Jonathan
James A. Moore chair in Parkinson's researchCANARIE Consortium Agreement: Network-enabled platforms program Stoessl, A Jonathan
Canadian Brain Imaging research Network (CBRAIN) Stoessl, A Jonathan
National Parkinson Foundation, Centre of Excellence Stoessl, A Jonathan
Teal, Philip
CREST - Carotid Revascularization Endarterectomy vs. Stenting Trial Teal, Philip
Economic Burden of Ischemic Stroke in CanadaCL3-18886-012 (The Perform Study) prevention of cerebrovascular and cardiovascular events of ischaemic origin with teRutroban in patients with a Teal, Philip
history of ischaemic stroke or transient ischaemic attack Teal, Philip
Albumin in Acute Stroke (ALIAS) TrialImportance of Conventional and Emerging Risk Factors for Stroke in Different Regions of the World and in Different Ethnic Groups: A Pilot Case-Control Teal, Philip
NTx 265-CP-201-IS: A Phase IIB Prospective, Randomized, Double-Blind, Placebo Controlled Study of NTx-265: Human Chorionic Gonadotropin (hCG) Teal, Philip
and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients MAGELLAN - Multicenter, rAndomized, parallel Group Efficacy superiority study Teal, Philip
in hospitalized medically iLL patients comparing rivaroxabAN with enoxaparinMP-124-A01: A Phase I Double-Blind, Placebo-Controlled, Ascending-Dose, clinical Study Investigating the Safety, Tolerability, and pharmacokinetics of MP- Teal, Philip
124 in Acute, Ischemic Stroke Patients.
Traboulsee, Anthony
VCHRI Clinical Trials Overhead Recovery (Non-contract research activities) Traboulsee, Anthony
Pseudoatrophy of the brain in multiple sclerosis Differentiation of degenerative and reparative T1 'BHs' in MS using MRI texture Traboulsee, Anthony
A Phase III Randomized, Rater-Blinded Study Comparing Two Annual Cycles ofIntravenous Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif) in Treatment-Naive Patients with Relapsing-Remitting Multiple Traboulsee, Anthony
A Phase III Randomized, Rater and Dose-Blinded Study Comparing Two Annual cycles of Intravenous Low and High-Dose Alemtuzumab (Study Drug) to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif) in Patients with Traboulsee, Anthony
Improving safety monitoring and design of future multiple sclerosis trials using Traboulsee, Anthony
IICT/A Phase III Double-blind, Randomized, Placebo-controlled Trial of Traboulsee, Anthony
Minocycline in Clinically Isolated Syndromes Do relapses effect disease progression? New perspectives on the natural Tremlett, Helen
The MaMs study. Malignancy and Multiple Sclerosis: incidence and impact of Tremlett, Helen
Tremlett, Helen
Epidemiological aspects of progression in multiple sclerosis The BeAMS study: long term benefits and adverse effects of beta-interferon for Tremlett, Helen
multiple sclerosisThe BeAMS study: long-term benefits and adverse effects of beta-interferon for Tremlett, Helen
Tremlett, Helen
Tremlett, Helen
Cognitive and psychosocial evaluation of patients with benign multiple sclerosis The BeAMS study: long term benefits and adverse effects of beta-interferon for Tremlett, Helen
multiple sclerosisUK Risk-sharing Scheme collaboration with the British Columbia Multiple Tremlett, Helen
Foundation of the Consortium of MS Centres Tremlett, Helen
Adherence to immunomodulatory drugs for MS 191622-090:A Multicentre, double-Blind, Randomized, Placebo-Controlled, Single-Treatment cycle, Parallel Evaluation of the Safety, Efficacy and Immunogenicity of Two Formulations of BOTOX (Botulinum Toxin Type A) Tsui, Joseph
MOBILITY: Project (MDs on Botox Utility) Observation Database Designed to Tsui, Joseph
Obtain Patient Reported Outcomes Following Treatment with Botox Wang, Yu Tian
Excitatory and inhibitory synaptic imbalance in neurodevelopmental disorders Investigation into the molecular mechanisms mediating excitotoxicity - Wang, Yu Tian
Activation of NR2A-containing NMDA receptor-mediated cell survival as a novel Wang, Yu Tian
and innovative therapeutic strategy in the treatment of stroke Wang, Yu Tian
Role of hippocampal synaptic plasticity in cue-induced relapsing Investigation into molecular mechanisms and physiological roles of activity- Wang, Yu Tian
Role of akt phosphorylation of GluR1 subunit of AMPA receptors in the receptor Wang, Yu Tian
Canadian Stroke Network (CSN) - Networks of Centres of Excellence Wang, Yu Tian
Development of a stroke model in non-human primates Canadian Stroke Network (CSN) - Networks of Centres of Excellence Wang, Yu Tian
Targeting cell death cascades in the neuro vascular-inflammatory unit Role of interaction between GABARAP and GABAA receptors in cerebral Wang, Yu Tian
Wang, Yu Tian
Role of NMDA receptors in recovery of dendritic structure after stroke Wang, Yu Tian
The role of TRP channels in neuronal death in cerebral ischemia Electrophysiological Comparison of STEMCELL's Test Media vs Invitrogen's Wang, Yu Tian
Wang, Yu Tian
Stipend: Role of hippocampal synaptic plasticity in cue-induced relapsing Research Allowance: Role of hippocampal synaptic plasticity in cue-induced Wang, Yu Tian
Role of ionotropic glutamate receptors in ischemic injury and dendritic spine Wang, Yu Tian
Woolfenden, Andrew
Interventional Management of Stroke Study III Anton, Hubert
The Prevalence and Course of Fatigue after Acute Spinal Cord Injury VHB-3015-PR01-v00: Pilot Study of Neurostep System in Patients with Gait Dhawan, Pankaj
Disorder Secondary to Central Nervous System Lesion VHB-3015-PR01-v00: Pilot Study of Neurostep System in Patients with Gait Dhawan, Pankaj
Disorder Secondary to Central Nervous System Lesion Creation of the web based learning module for the ASTeP - autonomic Krassioukov, Andrei
50,000.00US standards
Cardiovascular educational clinic for Paralympic athletes. Vancouver games Krassioukov, Andrei
28,000.00US 2010
Contribution Analysis to Assess the Performance of the Discovering the Power Townson, Andrea
Evidence-based management of secondary complications after spinal cord Townson, Andrea
Prevention of persistent post-concussion symdrome with cognitive behavioural Underwood, Heather
Abboud, Raja
Protocol: NA17598D, A multicenter, double-blind, placebo-controlled randomized trial of the efficacy safety and tolerbility of 12 months of once daily treatment with 5mg of RO3300074 in patients with symptomatic emphysema Abboud, Raja
Abboud, Raja
PATIENT REIMBURSEMENT ACCOUNT FOR STUDY na17598"Bronchiectasis Study": A Phase II Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy of 28 Day Oral Bai, Tony
Administration of AZD9668 in Patients with Brochiectasis.
Health-related quality of life in patients with chronic fibrosing interstitial lung Bai, Tony
disease managed in a multidisciplinary interstitial lung disease clinic Bryan, Stirling
Bryan, Stirling
Promoting high quality, patient-centred care through the use of patient-reported Bryan, Stirling
A systematic review and evidence synthesis of research on the regulation Bryan, Stirling
requirement for 24 hour registered nurse availability in long-term care facilities Bryan, Stirling
Developing a Broader Measure for Economic Evaluation Salary: Diesel exhaust inhalation in asthmatics: Oxidative stress as a mediator Carlsten, Christopher
Carlsten, Christopher
Start-Up FundsCedar dust exposure, airway inflammation and remodeling markers as Carlsten, Christopher
predictors of asthma recovery and severity Allergy, Genes and Environment Network (AllerGen) - Networks of Centres of Excellence International Partnership Initiative with the Karolinska Institute: Traffic-related air Carlsten, Christopher
pollution as a risk factor for the development of childhood asthma Relationship between early allergen exposure, nitrogen dioxide and ETS on Chan-Yeung, Moira
allergen sensitization and asthma in a high risk cohort Chan-Yeung, Moira
Primary preventiona of asthma: the impact of the multifaceted intervention Chan-Yeung, Moira
program in early life on outcomes in teenagers Daley, Denise
Canada Research Chair Tier II - Denise Daley Duronio, Vincent
Activation of macrophage growth and survival pathways by oxidized LDL Duronio, Vincent
Regulatory role of CXCL12 in the EAE model of MS Etminan, Mahyar
Association between sulpha containing drugs and glaucoma Fitzgerald, Mark
Fitzgerald, Mark
ECLIPSE: A Multicentre 3 Year Longitudinal Prospective Study to Identify Novel Endpoints and Compare These with Forced Expiratory Volume in 1 Second (FEV) for their ability to Measure and Predict COPD Severity and its Fitzgerald, Mark
Fitzgerald, Mark
Protocol 3174K1-200-Ca: The Effects of IMA-638 on Allergen-Induced Airway Fitzgerald, Mark
Responses and Airway Inflammation in Subjects with Mild Atopic Asthma BI1744CL - 1222.6: Randomized, Double-Blind, Placebo-Controlled, Parallel Group study to Assess the Efficacy (Bronchodilation) and safety of 4 weeks of once daily treatment of orally inhaled BI 1744 CL (2ug, 5ug, 10ug, 20ug) Fitzgerald, Mark
Q4160g:A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lyphilized and Aged Liquid Omalizumab in the Prevention of Allergen Induced Airway Fitzgerald, Mark
CIGE025A2433: International Registry of Real-World Outcomes for Asthma Fitzgerald, Mark
Allergy, Genes and Environment Network (AllerGen) - Networks of Centres of Excellence Programme B: Diagnositcs and Therapeutics - Clinical Investigator Fitzgerald, Mark
Fitzgerald, Mark
Protocl 1184.14:A 24 week (+24 week extension), randomised, placebo-controlled (only 1st 12-week period), double-blind, parallel-group, efficacy and safety comparison of Tiotropoum/Salmeterol (7.5 ug/25ug) inhalation powder in Fitzgerald, Mark
the morning…D0520C00010: A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess teh Efficacy of 28 Day Oral Administration of Fitzgerald, Mark
Asthma and health literacy in newcomer communities in the greater vancouver Fitzgerald, Mark
area (GVA): A population-based qualitative study CQAB149B2335S:A 26 week extension to a 26-week treatment, multicenter, randomized, double-blind, placebo-controlled, adaptive, seamless, parallel- group study to assess safety, tolerability and efficacy of two doses of Fitzgerald, Mark
Protocol: 3192K1-1002-CA: The effects of IMA-026 on Allergen-Induced Airway Responses and Airway Inflammation in subjects with Mild Atopic Asthma Fitzgerald, Mark
Allergy, Genes and Environment Network (AllerGen) - Networks of Centres of Excellence Fitzgerald, Mark
Clinical Investigator Collaborative - Programme B Diagnostics and Therapeutics Fitzgerald, Mark
Fleetham, John
Respiratory Sleep Disorders Research Unit Fleetham, John
UBC Vancouver Hospital Respiratory Faculty Development Fund Fleetham, John
Genetics of obstructive sleep apneaPIPF-004: A Randomized, Double-Blind, Placebo-Controlled, Phase 3, Three Arm Study of the Safety and Efficacy of Pirfenidone in Patients with Idiopathic Khalil, Nasreen
Pulmonary FibrosisPIPF-012: An Open-Label Extension Study of the Long-Term Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (IPF) Who Complete Khalil, Nasreen
the CAPACITY StudiesProtocol FPH03 STRIDE III: Long-Term Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients with Pulmonary Arterial Levy, Robert
A Multicentre 3 Year Longitudinal Prospective Study to Identify Novel Endpoints and Compare These with Forced Expiratory Volume in 1 Second (FEV1) for Their Ability to Measure and Predict COPD Severity and its Progression Over Levy, Robert
AC-055-302: SERAPHIN: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Event Driven, Phase III Study to Assess the Effects of ACT-064992 on Morbidity and Mortality in patients with Symptomatic Levy, Robert
Man, Paul
An integrated approach to blood biomarker discoveries in chronic obstructive Man, Paul
McWilliams, Annette
Miller, Chris
SC: Antimicrobial Effect of Various Nitric Oxide Generating Compounds/Liquids Protocols LVGX and LVGY: A Randomized Double-Blind, Study to Evaluate the Long-Term Safety and Efficacy of the Phosphodiesterase Type 5 (PDE5) Inhibitor Tadalafil in the Treatment of Patients with Pulmonary Arterial Ostrow, David
Pare, Peter
Genome-wide associations and environmental interactions in COPD in the Lung Pare, Peter
Health StudyCPR-0003: Study to Find Out If a New Medical Device Called the Intra-Bronchial Valve (IBV) is Safe and Effective to Use in Subjects With Severe Road, Jeremy
Road, Jeremy
Electrical Activation of the Diaphragm for Ventilatory Assist Clinical StudyTPI1020-203: A Multi-Center, Randomized, Double-Blind, Placebo and Active- Controlled, 6-Week Study to Evaluate the Safety, Tolerability and Road, Jeremy
Pharmacodynamic Activity of Inhaled TPI1020 in COPD Patients LAS-MD-CL26: A Randomzied, double-Blind, Placebo-Controlled, Parallel-Group, 6-Week Clinical Study to Assess the Effect of Inhaled Aclidinium Bromide ((LAS34273) 200 ug on Exercise Endurance and Lung Hyperinflation Road, Jeremy
EXACTT: A Randomized, Double-Blind, Placebo-Controlled Two-Year Trial to examine the changes in Exercise Endurance and COPD Patients Treated with Road, Jeremy
Tiotropoum (Spiriva HandiHaler) 18 ug Once Daily Effect of Inhalation of a Free combination of Tiotropium once Daily 18 mcg and Salmeterol Twice Daily 50 mcg versus a Fixed Combination of Fluticasone and Salmeterol Twice Daily (500/50 mcg) on Static Lung Volumes and Exercise Road, Jeremy
An Open-Label Phase Followed by a Randomized, Double-Blind, Placebo-Controlled Phase in a Study Designed to Evaluate Intravenous 2-0, 3-0 Desulfated Heparin (ODSH) in Hospitalized Subjects with Exacerbations of Road, Jeremy
CTP-6: A blinded placebo controlled single cross-over clinical trial to evaluate fungicidal activity with the topical application of 1% gaseous nitric oxide (gNO) Road, Jeremy
in subjects with moderate to severe Tinea Pedis(Athlete's Foot)Canada Research Chair in genetics of respiratory disease for Dr. Andrew Sandford, Andrew
Sandford, Andrew
Genetic susceptibility to inflammatory airway diseases Sin, Donald
Canada Research Chair in Chronic Obstructive Lung Disease - Dr. Don Sin Why are women at increased risk of chronic obstructive pulmonary disease and Sin, Donald
lung cancer? Is inflammation the missing link? TDE-PH-304: An Open-Label Extension Trial of UT015C in Subjects with Swiston, John
Swiston, John
Risk factors for hospital readmission in patients with COPD Protocol: AMB110094: A Post-Marketing Observational Surveillance Swiston, John
Tan-Hogg, Wan C.
BOLD STUDY: The burden of Chronic Obstructive Lung Disease Vancouver Coastal Health Authority - Operating Tan-Hogg, Wan C.
BOLD STUDY: The burden of Chronic Obstructive Lung Disease Tan-Hogg, Wan C.
Contract for services with Lung Cancer Prevention Program at BCCA.
Van Eeden, Stephanus Grant
Lung inflammation induced cardiovascular disease Ward, Helen
Canadian Agricultural Injury Surveillance ProgramA Randomized, Double-Blind, Placebo-Controlled, Phase 3 Three-Arm Study of the Safety and Efficacy of Pirfenidone in Patients with Idiopathic Pulmonary Wilcox, Pearce G.
IICT: Evaluation of a Decision Aid for Adult Cystic Fibrosis patients Considering Wilcox, Pearce G.
205.372-Spiriva Respimat(TM) Study: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess Long Term (one-year) Efficacy and Safety of Tiotropium Inhalation Solution 5ug (2 puffs of 2.5ug) Delivered by the Wilcox, Pearce G.
Protocol AC-052-321 BUILD 3: Effects of Bosentan on Morbidity and Mortality in Patients With Idiopathic Pulmonary Fibrosis - A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Event-Driven, Group Wilcox, Pearce G.
TIGER-2: A Phase 3, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of Denufosol Tetrasodium Inhalation Solution in Patients with Cystic Fibrosis Lung Disease Wilcox, Pearce G.
and FEV1=75 pA randomized, double-blind, placebo-controlled, parallel group, Phase II study to assess the efficacy of 28 day oral administration of AZD1236 in adult patients Wilcox, Pearce G.
IICT/Treatment of Aspergillus fumigatus in patients with cystic fibrosis: A Wilcox, Pearce G.
randomized, double-blind, placebo-controlled Trial.
"CNTO 888" A Phase 2, Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study Evaluating the Efficacy Wilcox, Pearce G.
and Safety of CNTO 888 Administered Intravenously.
ARTEMIS: A phase 3, randomized, double-blind,placebo-controlled, multi-center, parallel-group, event-driven study to evaluate the efficacy and safety of Wilcox, Pearce G.
Ambrisentan in subjects with Early Idiopathic Pulmonary Fibrosis (IPF).
AC-055B201: A double-blind, randomized, placebo-controlled, multicenter, parallel group study to evaluate the efficacy, safety, and tolerability of macitentan in patients with idiopathic pulmonary fibrosis. (MUSIC: Macitentan Wilcox, Pearce G.
USe in an IdiA Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-770 in Subjects with Cystic Wilcox, Pearce G.
Cibere, Jolanda
Development of a Model for the MRI Progression of Knee Osteoarthritis Cardiovascular morbidity and mortality associated with the use of Esdaile, John
corticosteroids in patients with rheumatiod arthritis. A population-based study IMPAKT-HIP - Investigations of mobility, physical activity, and knowledge Esdaile, John
translation in hip painA Retrospective Assessment of Infusion Reactions, Infusion Reaction Management and Outcomes with Infliximab Therapy in a Community Infusion Kelsall, John T.
ClinicEvaluating care for rheumatoid arthritis and preventing work disability in Lacaille, Diane
Shojania, Kam

Source: http://www.medicine.ubc.ca/files/annual_reports/2009/2009_grants_and_research_awards.pdf